These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29568639)

  • 1. HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study.
    Mogambery JC; Dawood H; Wilson D; Moodley A
    South Afr J HIV Med; 2017; 18(1):732. PubMed ID: 29568639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    Molinaro M; Sacktor N; Nakigozi G; Anok A; Batte J; Kisakye A; Myanja R; Nakasujja N; Robertson KR; Gray RH; Wawer MJ; Saylor D
    J Acquir Immune Defic Syndr; 2020 Mar; 83(3):278-283. PubMed ID: 32032278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
    Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
    PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
    Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
    BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive Disorders in HIV-positive Patients.
    Padole PS; Padhiyar RN; Yadav DS; Chavan SA
    J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.
    Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY
    HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.
    Cross S; Önen N; Gase A; Overton ET; Ances BM
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1114-22. PubMed ID: 24114509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological manifestation with special reference to HIV-associated neurocognitive disorder (HAND) among people on anti-retroviral treatment in India.
    Shaik RA; Holyachi S; Ahmad MS; Ahmad RK; Yusuf M; Khan M; Almutairi AB; Alghuyaythat WKZ
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6999-7004. PubMed ID: 34859862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital.
    Mugendi AG; Kubo MN; Nyamu DG; Mwaniki LM; Wahome SK; Haberer JE
    Neurol Res Int; 2019; 2019():5173289. PubMed ID: 31781391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is International HIV Dementia Scale good enough to diagnose HIV-associated neurocognitive disorders?
    Himanshu D; Tandon R; Kumar S; Sawlani KK; Verma SK; Misra R; Atam V
    J Family Med Prim Care; 2022 Sep; 11(9):5060-5064. PubMed ID: 36505608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens.
    Rodrigues J; Lowton K
    S Afr J Psychiatr; 2023; 29():2071. PubMed ID: 37795459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
    Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
    J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
    Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
    J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
    Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
    PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
    Troncoso FT; Conterno Lde O
    Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
    Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
    AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of the HIV-associated neurocognitive disorders among adults living with HIV in Dodoma region, central Tanzania: A cross-sectional study.
    Nyundo AA
    PLoS One; 2023; 18(5):e0285761. PubMed ID: 37228133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for neurocognitive impairment in HIV-infected patients and comparison of different screening tools.
    de Souza EM; Buoniconti CS; Valim FC; Moura AS
    Dement Neuropsychol; 2016; 10(1):42-46. PubMed ID: 29213430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
    Kamal S; Locatelli I; Wandeler G; Sehhat A; Bugnon O; Metral M; Du Pasquier R; Gutbrod K; Cavassini M; Schneider MP;
    Open Forum Infect Dis; 2017; 4(2):ofx070. PubMed ID: 28584853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.